Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues

Frontiers in Physiology

Volumn 3 MAR, Issue , 2012, Pages

  Martinez, Y ^a   Dubois Dauphin, M ^a   Krause, K H ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cell therapy; Cell transplantation; Drug screening; Embryonic stem cell; Engineered neural tissue; Induced pluripotent stem cells; Neural differentiation; Neurons

Indexed keywords

EID: 84866270039     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00047     Document Type: Article

References (111)

1. Alves, G., Forsaa, E. B., Pedersen, K. F., Dreetz Gjerstad, M., and Larsen, J. P. (2008). Epidemiology of Parkinson's disease. J. Neurol. 255(Suppl. 5), 18-32.
2. Anokye-Danso, F., Trivedi, C. M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., Zhang, Y., Yang, W., Gruber, P. J., Epstein, J. A., and Morrisey, E. E. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripo-tency. Cell Stem Cell 8, 376-388.
3. Aubry, L., Bugi, A., Lefort, N., Rousseau, F., Peschanski, M., and Perrier, A. L. (2008). Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. U.S.A. 105, 16707-16712.
4. Azari, H., Osborne, G. W., Yasuda, T., Golmohammadi, M. G., Rahman, M., Deleyrolle, L. P., Esfandi-ari, E., Adams, D. J., Scheffler, B., Steindler, D. A., and Reynolds, B. A. (2011). Purification of immature neuronal cells from neural stem cell progeny. PLoS ONE 6, e20941. doi:10.1371/journal.pone.0020941
5. Aznar, J., and Sanchez, J. L. (2011). Embryonic stem cells: are useful in clinic treatments? J. Physiol. Biochem. 67, 141-144.
6. Baek, K. H., Zaslavsky, A., Lynch, R. C., Britt, C., Okada, Y., Siarey, R. J., Lensch, M. W., Park, I. H., Yoon, S. S., Minami, T., Korenberg, J. R., Folkman, J., Daley, G. Q., Aird, W. C., Galdzicki, Z., and Ryeom, S. (2009). Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459, 1126-1130.
7. Bal-Price, A. K., Hogberg, H. T., Buzanska, L., Lenas, P., Van Vliet, E., and Hartung, T. (2010). In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology 31, 545-554.
8. Barbaric, I., Gokhale, P. J., and Andrews, P. W. (2010). High-content screening of small compounds on human embryonic stem cells. Biochem. Soc. Trans. 38, 1046-1050.
9. Barrett, R. D., Bennet, L., Davidson, J., Dean, J. M., George, S., Emerald, B. S., and Gunn, A. J. (2007). Destruction and reconstruction: hypoxia and the developing brain. Birth Defects Res. C Embryo Today 81, 163-176.
10. Ben-Hur, T., Idelson, M., Khaner, H., Pera, M., Reinhartz, E., Itzik, A., and Reubinoff,B. E. (2004). Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 22, 1246-1255.
11. Bharti, K., Miller, S. S., and Arnheiter, H. (2011). The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 24, 21-34.
12. Bhattacharya, B., Puri, S., and Puri, R. K. (2009). A review of gene expression profiling of human embryonic stem cell lines and their differentiated progeny. Curr. Stem Cell Res. Ther. 4, 98-106.
13. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., Ziller, M., Croft, G. F., Amoroso, M. W., Oakley, D. H., Gnirke, A., Eggan, K., and Meissner, A. (2011). Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452.
14. Breier, J. M., Gassmann, K., Kayser, R., Stegeman, H., De Groot, D., Fritsche, E., and Shafer, T. J. (2010). Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 32, 4-15.
15. Breier, J. M., Radio, N. M., Mundy, W. R., and Shafer, T. J. (2008). Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol. Sci. 105, 119-133.
16. Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., Mccarthy, S., Sebat, J., and Gage, F. H. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221-225.
17. Buxbaum, J. D., and Sklar, P. (2011). Human induced pluripotent stem cells: a new model for schizophrenia? Cell Stem Cell 8, 461-462.
18. Calabresi, P., Di Filippo, M., Ghiglieri, V., Tambasco, N., and Picconi, B. (2010). Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol. 9, 1106-1117.
19. Chiang, C. H., Su, Y., Wen, Z., Yorit-omo, N., Ross, C. A., Margolis, R. L., Song, H., and Ming, G. L. (2011). Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 16, 358-360.
20. Chiba, S., Lee, Y. M., Zhou, W., and Freed, C. R. (2008). Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 26, 2810-2820.
21. Cho, M. S., Hwang, D. Y., and Kim, D. W. (2008). Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat. Protoc. 3, 1888-1894.
22. Choo, A. B., Tan, H. L., Ang, S. N., Fong, W. J., Chin, A., Lo, J., Zheng, L., Hentze, H., Philp, R. J., Oh, S. K., and Yap, M. (2008). Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26, 1454-1463.
23. Coecke, S., Goldberg, A. M., Allen, S., Buzanska, L., Calamandrei, G., Crofton, K., Hareng, L., Hartung, T., Knaut, H., Honegger, P., Jacobs, M., Lein, P., Li, A., Mundy, W., Owen, D., Schneider, S., Silbergeld, E., Reum, T., Trnovec, T., Monnet-Tschudi, F., and Bal-Price,A. (2007). Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ. Health Perspect. 115, 924-931.
24. Cooper, O., Hargus, G., Deleidi, M., Blak, A., Osborn, T., Marlow, E., Lee, K., Levy, A., Perez-Torres, E., Yow, A., and Isacson, O. (2010). Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci. 45, 258-266.
25. Daadi, M. M., and Steinberg, G. K. (2009). Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy. Regen. Med. 4, 251-263.
26. Danovi, D., Falk, A., Humphreys, P., Vickers, R., Tinsley, J., Smith, A. G., and Pollard, S. M. (2010). Imaging-based chemical screens using normal and glioma-derived neural stem cells. Biochem. Soc. Trans. 38, 1067-1071.
27. Dantuma, E., Merchant, S., and Sugaya, K. (2010). Stem cells for the treatment of neurodegenerative diseases. Stem Cell Res. Ther. 1, 37.
28. Deep-Soboslay, A., Benes, F. M., Haroutunian, V., Ellis, J. K., Kleinman, J. E., and Hyde, T. M. (2011). Psychiatric brain banking: three perspectives on current trends and future directions. Biol. Psychiatry 69, 104-112.
29. Dhara, S. K., and Stice, S. L. (2008). Neural differentiation of human embryonic stem cells. J. Cell. Biochem. 105, 633-640.
30. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C. E., and Eggan, K. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
31. Ding, Y. X., Wei, L. C., Wang, Y. Z., Cao, R., Wang, X., and Chen, L. W. (2011). Molecular manipulation targeting regulation of dopaminer-gic differentiation and proliferation of neural stem cells or pluripotent stem cells. CNS Neurol. Disord. Drug Targets 10, 517-528.
32. Ebert,A. D., and Svendsen, C. N. (2010). Human stem cells and drug screening: opportunities and challenges. Nat. Rev. Drug Discov. 9, 367-372.
33. Ebert, A. D., Yu, J., Rose, F. F., Jr., Mattis, V. B., Lorson, C. L., Thomson, J. A., and Svendsen, C. N. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280.
34. Erceg, S., Ronaghi, M., Oria, M., Rosello, M. G., Arago, M. A., Lopez, M. G., Radojevic, I., Moreno-Manzano, V., Rodriguez-Jimenez, F. J., Bhattacharya, S. S., Cordoba, J., and Stojkovic, M. (2010). Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 28, 1541-1549.
35. Frank, S., and Biglan, K. (2007). Long-term fetal cell transplant in Hunting-ton disease: stayin' alive. Neurology 68, 2055-2056.
36. Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W. Y., Dumouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., Eidelberg, D., and Fahn,S. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710-719.
37. Gallina,P.,Paganini, M., Lombardini,L., Mascalchi, M., Porfirio, B., Gadda, D., Marini, M., Pinzani, P., Salvianti, F., Crescioli, C., Bucciantini, S., Mechi, C., Sarchielli, E., Romoli, A. M., Bertini, E., Urbani, S., Bartolozzi, B., De Cristofaro, M. T., Piacentini, S., Saccardi, R., Pupi, A., Vannelli, G. B., and Di Lorenzo, N. (2010). Human striatal neurob-lasts develop and build a striatal-like structure into the brain of Hunting-ton's disease patients after transplantation. Exp. Neurol. 222, 30-41.
38. Geron Corporation. (2009). World's first clinical trial of human embryonic stem cell therapy cleared. Regen. Med. 4, 161.
39. Gonzalez, F., Boue, S., and Izpisua Belmonte, J. C. (2011). Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet. 12, 231-242.
40. Goto, S., Hirano, A., and Matsumoto, S. (1990). Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases. Ann. Neurol. 27, 520-527.
41. Gunewardene, N., Dottori, M., and Nayagam, B. A. (2011). The convergence of cochlear implantation with induced pluripotent stem cell therapy. Stem Cell Rev. PMID: 21956409. [Epub ahead of print].
42. Hargus, G., Cooper, O., Deleidi, M., Levy, A., Lee, K., Marlow, E., Yow, A., Soldner, F., Hockemeyer, D., Hallett, P. J., Osborn, T., Jaenisch, R., and Isacson, O. (2010). Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. U.S.A. 107, 15921-15926.
43. Hatami, M., Mehrjardi, N. Z., Kiani, S., Hemmesi, K., Azizi, H., Shahverdi, A., and Baharvand, H. (2009). Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy 11, 618-630.
44. Hochedlinger, K., and Jaenisch, R. (2006). Nuclear reprogramming and pluripotency. Nature 441, 1061-1067.
45. Hotta, A., Cheung, A. Y., Farra, N., Gar-cha, K., Chang, W. Y., Pasceri, P., Stanford, W. L., and Ellis, J. (2009). EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat. Protoc. 4, 1828-1844.
46. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., and Melton, D. A. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275.
47. Jagatsinh, Y. (2009). Intrathecal baclofen: Its effect on symptoms and activities of daily living in severe spasticity due to spinal cord injuries: A pilot study. Indian J. Orthop. 43, 46-49.
48. Johnson, P. J., Tatara, A., Mccreedy, D. A., Shiu, A., and Sakiyama-Elbert, S. E. (2010). Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 6, 5127-5137.
49. Kawaguchi, D., Yoshimatsu, T., Hozumi, K., and Gotoh, Y. (2008). Selection of differentiating cells by different levels of delta-like 1 among neural precursor cells in the developing mouse telencephalon. Development 135, 3849-3858.
50. Kerr, C. L., Letzen, B. S., Hill, C. M., Agrawal, G., Thakor, N. V., Sterneck-ert, J. L., Gearhart, J. D., and All, A. H. (2010). Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int. J. Neurosci. 120, 305-313.
51. Kim, H. J. (2011). Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim. Bio-phys. Acta 1812, 1-11.
52. Kim, J., Efe, J. A., Zhu, S., Talan-tova, M., Yuan, X., Wang, S., Lip-ton, S. A., Zhang, K., and Ding, S. (2011). Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. U.S.A. 108, 7838-7843.
53. Leach, J. B., Achyuta, A. K., and Murthy, S. K. (2010). Bridging the divide between neuroprosthetic design, tissue engineering and neurobiology. Front. Neuroengineering 2:18. doi:10.3389/neuro.16.018.2009
54. Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., Ganat, Y. M., Menon, J., Shimizu, F., Viale, A., Tabar, V., Sadelain, M., and Studer, L. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406.
55. Lee, K. B., Choi, J. H., Byun, K., Chung, K. H., Ahn, J. H., Jeong, G. B., Hwang, I. K., Kim, S., Won, M. H., and Lee, B. (2012). Recovery of CNS pathway innervating the sciatic nerve following transplantation of human neural stem cells in rat spinal cord injury. Cell. Mol. Neurobiol. 32, 149-157.
56. Lees, J. G., Lim, S. A., Croll, T., Williams, G., Lui, S., Cooper-White, J., Mcquade, L. R., Mathiyalagan, B., and Tuch, B. E. (2007). Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. Regen. Med. 2, 289-300.
57. Lein, P., Locke, P., and Goldberg, A. (2007). Meeting report: alternatives for developmental neurotoxicity testing. Environ. Health Perspect. 115, 764-768.
58. Li, M. (2002). Lineage selection for generation and amplification of neural precursor cells. Methods Mol. Biol. 185, 205-215.
59. Li, W., Sun, W., Zhang, Y., Wei, W., Ambasudhan, R., Xia, P., Talantova, M., Lin, T., Kim, J., Wang, X., Kim, W. R., Lipton, S. A., Zhang, K., and Ding, S. (2011). Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc. Natl. Acad. Sci. U.S.A. 108, 8299-8304.
60. Lim, D. Y., Ng, Y. H., Lee, J., Mueller, M., Choo, A. B., and Wong, V. V. (2011). Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells. J. Biotechnol. 153, 77-85.
61. Marchetto, M. C., Winner, B., and Gage, F. H. (2010). Pluripotent stem cells in neurodegenerative and neurode-velopmental diseases. Hum. Mol. Genet. 19, R71-R76.
62. Martinez-Fernandez, A., Nelson, T. J., and Terzic, A. (2011). Nuclear repro-gramming strategy modulates differentiation potential of induced pluripotent stem cells. J. Cardiovasc. Transl. Res. 4, 131-137.
63. Martinez, Y., Bena, F., Gimelli, S., Tirefort, D., Dubois-Dauphin, M., Krause, K. H., and Preynat-Seauve, O. (2011). Cellular diversity within embryonic stem cells: pluripotent clonal sublines show distinct differentiation potential. J. Cell. Mol. Med. 16, 456-467.
64. Moghadam, F. H., Alaie, H., Karbalaie, K., Tanhaei, S., Nasr Esfahani, M. H., and Baharvand, H. (2009). Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. Differentiation 78, 59-68.
65. Molcanyi, M., Riess, P., Bentz, K., Maegele, M., Hescheler, J., Schafke, B., Trapp, T., Neugebauer, E., Klug, N., and Schafer, U. (2007). Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain. J. Neuro-trauma 24, 625-637.
66. Moors, M., Rockel, T. D., Abel, J., Cline, J. E., Gassmann, K., Schreiber, T., Schuwald, J., Weinmann, N., and Fritsche, E. (2009). Human neu-rospheres as three-dimensional cellular systems for developmental neu-rotoxicity testing. Environ. Health Perspect. 117, 1131-1138.
67. Nat, R., and Hovatta, O. (2004). In vitro neural differentiation of human embryonic stem cells. J. Cell. Mol. Med. 8, 570-571.
68. Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schule, B., Dolmetsch, R. E., Langston,W.,Palmer, T. D., and Pera, R. R. (2011). LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267-280.
69. Niapour, A., Karamali, F., Nemati, S., Taghipour, Z., Mardani, M., Nasr-Esfahani, M. H., and Baharvand, H. (2011). Co-transplantation of human embryonic stem cell-derived neural progenitors and schwann cells in a rat spinal cord contusion injury model elicits a distinct neuro-genesis and functional recovery. Cell Transplant. PMID: 21944670. [Epub ahead of print].
70. Ohi, Y., Qin, H., Hong, C., Blouin, L., Polo, J. M., Guo, T., Qi, Z., Downey, S. L., Manos, P. D., Rossi, D. J., Yu, J., Hebrok, M., Hochedlinger, K., Costello, J. F., Song, J. S., and Ramalho-Santos, M. (2011). Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13, 541-549.
71. Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K., Shibata, T., Kunisada, T., Takahashi, M., Takahashi, J., Saji, H., and Yamanaka, S. (2011). A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409-412.
72. Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., and Freeman, T. B. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54, 403-414.
73. Pal, R., Mamidi, M. K., Das, A. K., and Bhonde, R. (2011). Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity. J. Cell. Physiol. 226, 1583-1595.
74. Pang, Z. P., Yang, N., Vierbuchen, T., Ostermeier, A., Fuentes, D. R., Yang, T. Q., Citri, A., Sebastiano,V., Marro, S., Sudhof, T. C., and Wernig, M. (2011). Induction of human neuronal cells by defined transcription factors. Nature 476, 220-223.
75. Pankratz, M. T., Li, X. J., Lavaute, T. M., Lyons, E. A., Chen, X., and Zhang, S. C. (2007). Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25, 1511-1520.
76. Park, I. H., Arora, N., Huo, H., Maher-ali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., and Daley, G. Q. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886.
77. Pfisterer, U., Kirkeby, A., Torper, O., Wood, J., Nelander, J., Dufour, A., Bjorklund, A., Lindvall, O., Jakobsson, J., and Parmar,M. (2011). Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 108, 10343-10348.
78. Preynat-Seauve, O., and Krause, K. H. (2011). Stem cell sources for regenerative medicine:theimmunological point of view. Semin. Immunopathol. 33, 519-524.
79. Preynat-Seauve, O., Suter, D. M., Tire-fort, D., Turchi, L., Virolle, T., Chneiweiss, H., Foti, M., Lobri-nus, J. A., Stoppini, L., Feki, A., Dubois-Dauphin,M.,and Krause,K. H. (2009). Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells 27, 509-520.
80. Qin, W., Bauman, W. A., and Cardozo, C. (2010). Bone and muscle loss after spinal cord injury: organ interactions. Ann. N. Y. Acad. Sci. 1211, 66-84.
81. Radio, N. M., and Mundy, W. R. (2008). Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29, 361-376.
82. Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., and Ben-Hur, T. (2001). Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19, 1134-1140.
83. Riess, P., Molcanyi, M., Bentz, K., Maegele, M., Simanski, C., Carl-itscheck, C., Schneider, A., Hescheler, J., Bouillon, B., Schafer, U., and Neugebauer, E. (2007). Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J. Neurotrauma 24, 216-225.
84. Rossi, S. L., Nistor, G., Wyatt, T., Yin, H. Z., Poole, A. J., Weiss, J. H., Gardener, M. J., Dijkstra, S., Fischer, D. F., and Keirstead, H. S. (2010). Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS ONE 5, e11852. doi:10.1371/journal.pone.0011852
85. Roy, N. S., Cleren, C., Singh, S. K., Yang, L., Beal, M. F., and Goldman, S. A. (2006). Functional engraftment of human ES cell-derived dopamin-ergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12, 1259-1268.
86. Sasai, N., Yakura, R., Kamiya, D., Nakazawa, Y., and Sasai, Y. (2008). Ectodermal factor restricts meso-derm differentiation by inhibiting p53. Cell 133, 878-890.
87. Schuldiner, M., Itskovitz-Eldor, J., and Benvenisty, N. (2003). Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21, 257-265.
88. Schwartz, P. H., Brick, D. J., Stover, A. E., Loring, J. F., and Muller, F. J. (2008). Differentiation of neural lineage cells from human pluripotent stem cells. Methods 45, 142-158.
89. Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C., and Krainc, D. (2011). Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 31, 5970-5976.
90. Sethi, K. D. (2010). The impact of levodopa on quality of life in patients with Parkinson disease. Neurologist 16, 76-83.
91. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., Isacson, O., and Jaenisch, R. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977.
92. Song, J., Lee, S. T., Kang, W., Park, J. E., Chu, K., Lee, S. E., Hwang, T., Chung, H., and Kim, M. (2007). Humanembryonicstem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci. Lett. 423, 58-61.
93. Suter, D. M., and Krause, K. H. (2008). Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy. J. Pathol. 215, 355-368.
94. Suter, D. M., Preynat-Seauve, O., Tirefort, D., Feki, A., and Krause, K. H. (2009). Phenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells. J. Cell. Mol. Med. 13, 3517-3527.
95. Swistowski, A., Peng, J., Han, Y., Swis-towska, A. M., Rao, M. S., and Zeng, X. (2009). Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE 4, e6233. doi:10.1371/journal.pone.0006233
96. Swistowski, A., Peng, J., Liu, Q., Mali, P., Rao, M. S., Cheng, L., and Zeng, X. (2010). Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28, 1893-1904.
97. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
98. Tan, H. L., Fong, W. J., Lee, E. H., Yap, M., and Choo, A. (2009). mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells 27, 1792-1801.
99. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998). Embryonic stem cell lines derived from human blas-tocysts. Science 282, 1145-1147.
100. Tian, C., Wang, Y., Sun, L., Ma, K., and Zheng, J. C. (2011). Reprogrammed mouse astrocytes retain a "memory" of tissue origin and possess more tendencies for neuronal differentiation than reprogrammed mouse embryonic fibroblasts. Protein Cell 2, 128-140.
101. Tuszynski, M. H. (2007). Nerve growth factor gene therapy in Alzheimer disease.Alzheimer Dis. Assoc. Disord. 21, 179-189.
102. Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Sudhof, T. C., and Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041.
103. Wang, A., Tang, Z., Park, I. H., Zhu, Y., Patel, S., Daley, G. Q., and Li, S. (2011). Induced pluripotent stem cells for neural tissue engineering. Biomaterials 32, 5023-5032.
104. Wang, Q., Matsumoto, Y., Shindo, T., Miyake, K., Shindo, A., Kawanishi, M., Kawai, N., Tamiya, T., and Nagao, S. (2006). Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J. Med. Invest. 53, 61-69.
105. Warren, G., and Yellowlees, P. (1990). The prevalence of Huntington's disease. Med. J. Aust. 153, 629.
106. Wilby, M. J., Muir, E. M., Fok-Seang, J., Gour, B. J., Blaschuk, O. W., and Fawcett, J. W. (1999). N-Cadherin inhibits Schwann cell migration on astrocytes. Mol. Cell. Neurosci. 14, 66-84.
107. Yamanaka, S. (2008). Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif. 41 (Suppl. 1), 51-56.
108. Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., and Dolmetsch, R. E. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234.
109. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., and Yamanaka, S. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5, 237-241.
110. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, Ii" and Thomson, J. A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
111. Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., Siuzdak, G., Scholer, H. R., Duan, L., and Ding, S. (2009). Generation of induced pluripotent stem cells using recom-binant proteins. Cell Stem Cell 4, 381-384